Literature DB >> 33104057

Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?

Philip A Mudd1, Kenneth E Remy2,3.   

Abstract

Ongoing observational clinical research has prioritized understanding the human immune response to SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic. Several recent studies suggest that immune dysregulation with early and prolonged adaptive immune system activation can result in cellular exhaustion. In this issue of the JCI, Files et al. compared cellular immune phenotypes during the first two months of COVID-19 in hospitalized and less severe, non-hospitalized patients. The authors utilized flow cytometry to analyze circulating peripheral blood mononuclear cells. Both patient cohorts maintained B and T cell phenotypes consistent with activation and cellular exhaustion throughout the first two months of infection. Additionally, follow-up samples from the non-hospitalized patient cohort showed that activation markers and cellular exhaustion increased over time. These findings illustrate the persistent nature of the adaptive immune system changes that have been noted in COVID-19 and suggest longer term effects that may shape the maintenance of immunity to SARS-CoV-2.

Entities:  

Mesh:

Year:  2021        PMID: 33104057      PMCID: PMC7773393          DOI: 10.1172/JCI143928

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

Review 1.  Protective and Harmful Immunity to RSV Infection.

Authors:  Peter J M Openshaw; Chris Chiu; Fiona J Culley; Cecilia Johansson
Journal:  Annu Rev Immunol       Date:  2017-02-06       Impact factor: 28.527

2.  Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.

Authors:  Jacob K Files; Sushma Boppana; Mildred D Perez; Sanghita Sarkar; Kelsey E Lowman; Kai Qin; Sarah Sterrett; Eric Carlin; Anju Bansal; Steffanie Sabbaj; Dustin M Long; Olaf Kutsch; James Kobie; Paul A Goepfert; Nathan Erdmann
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

3.  Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.

Authors:  Ding Shi; Wenrui Wu; Qing Wang; Kaijin Xu; Jiaojiao Xie; Jingjing Wu; Longxian Lv; Jifang Sheng; Jing Guo; Kaicen Wang; Daiqiong Fang; Yating Li; Lanjuan Li
Journal:  J Infect Dis       Date:  2020-08-17       Impact factor: 5.226

4.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.

Authors:  Divij Mathew; Josephine R Giles; Amy E Baxter; Derek A Oldridge; Allison R Greenplate; Jennifer E Wu; Cécile Alanio; Leticia Kuri-Cervantes; M Betina Pampena; Kurt D'Andrea; Sasikanth Manne; Zeyu Chen; Yinghui Jane Huang; John P Reilly; Ariel R Weisman; Caroline A G Ittner; Oliva Kuthuru; Jeanette Dougherty; Kito Nzingha; Nicholas Han; Justin Kim; Ajinkya Pattekar; Eileen C Goodwin; Elizabeth M Anderson; Madison E Weirick; Sigrid Gouma; Claudia P Arevalo; Marcus J Bolton; Fang Chen; Simon F Lacey; Holly Ramage; Sara Cherry; Scott E Hensley; Sokratis A Apostolidis; Alexander C Huang; Laura A Vella; Michael R Betts; Nuala J Meyer; E John Wherry
Journal:  Science       Date:  2020-07-15       Impact factor: 47.728

5.  Novel correlates of protection against pandemic H1N1 influenza A virus infection.

Authors:  Sophia Ng; Raffael Nachbagauer; Angel Balmaseda; Daniel Stadlbauer; Sergio Ojeda; Mayuri Patel; Arvind Rajabhathor; Roger Lopez; Andrea F Guglia; Nery Sanchez; Fatima Amanat; Lionel Gresh; Guillermina Kuan; Florian Krammer; Aubree Gordon
Journal:  Nat Med       Date:  2019-06-03       Impact factor: 53.440

6.  Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.

Authors:  Kenneth E Remy; Monty Mazer; David A Striker; Ali H Ellebedy; Andrew H Walton; Jacqueline Unsinger; Teresa M Blood; Philip A Mudd; Daehan J Yi; Daniel A Mannion; Dale F Osborne; R Scott Martin; Nitin J Anand; James P Bosanquet; Jane Blood; Anne M Drewry; Charles C Caldwell; Isaiah R Turnbull; Scott C Brakenridge; Lyle L Moldwawer; Richard S Hotchkiss
Journal:  JCI Insight       Date:  2020-09-03

7.  Longitudinal analyses reveal immunological misfiring in severe COVID-19.

Authors:  Carolina Lucas; Patrick Wong; Jon Klein; Tiago B R Castro; Julio Silva; Maria Sundaram; Mallory K Ellingson; Tianyang Mao; Ji Eun Oh; Benjamin Israelow; Takehiro Takahashi; Maria Tokuyama; Peiwen Lu; Arvind Venkataraman; Annsea Park; Subhasis Mohanty; Haowei Wang; Anne L Wyllie; Chantal B F Vogels; Rebecca Earnest; Sarah Lapidus; Isabel M Ott; Adam J Moore; M Catherine Muenker; John B Fournier; Melissa Campbell; Camila D Odio; Arnau Casanovas-Massana; Roy Herbst; Albert C Shaw; Ruslan Medzhitov; Wade L Schulz; Nathan D Grubaugh; Charles Dela Cruz; Shelli Farhadian; Albert I Ko; Saad B Omer; Akiko Iwasaki
Journal:  Nature       Date:  2020-07-27       Impact factor: 49.962

8.  Association of Interleukin 7 Immunotherapy With Lymphocyte Counts Among Patients With Severe Coronavirus Disease 2019 (COVID-19).

Authors:  Pierre Francois Laterre; Bruno François; Christine Collienne; Philippe Hantson; Robin Jeannet; Kenneth E Remy; Richard S Hotchkiss
Journal:  JAMA Netw Open       Date:  2020-07-01

9.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Authors:  Alba Grifoni; Daniela Weiskopf; Sydney I Ramirez; Jose Mateus; Jennifer M Dan; Carolyn Rydyznski Moderbacher; Stephen A Rawlings; Aaron Sutherland; Lakshmanane Premkumar; Ramesh S Jadi; Daniel Marrama; Aravinda M de Silva; April Frazier; Aaron F Carlin; Jason A Greenbaum; Bjoern Peters; Florian Krammer; Davey M Smith; Shane Crotty; Alessandro Sette
Journal:  Cell       Date:  2020-05-20       Impact factor: 66.850

10.  Humoral Immune Response to SARS-CoV-2 in Iceland.

Authors:  Daniel F Gudbjartsson; Gudmundur L Norddahl; Pall Melsted; Kristbjorg Gunnarsdottir; Hilma Holm; Elias Eythorsson; Asgeir O Arnthorsson; Dadi Helgason; Kristbjorg Bjarnadottir; Ragnar F Ingvarsson; Brynja Thorsteinsdottir; Steinunn Kristjansdottir; Kolbrun Birgisdottir; Anna M Kristinsdottir; Martin I Sigurdsson; Gudny A Arnadottir; Erna V Ivarsdottir; Margret Andresdottir; Frosti Jonsson; Arna B Agustsdottir; Jonas Berglund; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Magnus Gottfredsson; Olafia S Gretarsdottir; Steinunn Gudmundsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Agnar Helgason; Brynjar O Jensson; Aslaug Jonasdottir; Hakon Jonsson; Thordur Kristjansson; Karl G Kristinsson; Droplaug N Magnusdottir; Olafur T Magnusson; Lovisa B Olafsdottir; Solvi Rognvaldsson; Louise le Roux; Gudrun Sigmundsdottir; Asgeir Sigurdsson; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Marianna Thordardottir; Jona Saemundsdottir; S Hjortur Kristjansson; Kamilla S Josefsdottir; Gisli Masson; Gudmundur Georgsson; Mar Kristjansson; Alma Moller; Runolfur Palsson; Thorolfur Gudnason; Unnur Thorsteinsdottir; Ingileif Jonsdottir; Patrick Sulem; Kari Stefansson
Journal:  N Engl J Med       Date:  2020-09-01       Impact factor: 91.245

View more
  5 in total

1.  Post-surgical pyoderma gangrenosum in otherwise healthy patient with history of COVID-19.

Authors:  Matthew D Rich; Thomas J Sorenson; Warren Schubert
Journal:  Breast J       Date:  2021-05-24       Impact factor: 2.269

Review 2.  Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Authors:  Tamas Fulop; Anis Larbi; Graham Pawelec; Alan A Cohen; Guillaume Provost; Abedelouahed Khalil; Guy Lacombe; Serafim Rodrigues; Mathieu Desroches; Katsuiku Hirokawa; Claudio Franceschi; Jacek M Witkowski
Journal:  Vaccines (Basel)       Date:  2022-04-13

Review 3.  Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research.

Authors:  Philip A Verhoef; Sujatha Kannan; Jamie L Sturgill; Elizabeth W Tucker; Peter E Morris; Andrew C Miller; Travis R Sexton; Jay L Koyner; Rana Hejal; Scott C Brakenridge; Lyle L Moldawer; Richard S Hotchkiss; Teresa M Blood; Monty B Mazer; Scott Bolesta; Sheila A Alexander; Donna Lee Armaignac; Steven L Shein; Christopher Jones; Caroline D Hoemann; Allan Doctor; Stuart H Friess; Robert I Parker; Alexandre T Rotta; Kenneth E Remy
Journal:  Crit Care Explor       Date:  2021-03-12

4.  Methylprednisolone Treatment Versus Standard Supportive Care for Adult COVID-19 Mechanically Ventilated, Acute Respiratory Distress Syndrome Patients.

Authors:  Masood Ur Rahman; Satish Chandrasekhar Nair; Mehraj Ud Din; Mohammed Reidwan Dar; Murriam Masood; Al Reem Salem Al Menhali; Mouza Mohammed Al Nuaimi; Jayadevan Sreedharan; Huda Imam Gasmelseed; Asad Afroz Khan
Journal:  SN Compr Clin Med       Date:  2022-01-03

Review 5.  Stem cell therapy for COVID-19 pneumonia.

Authors:  Maziar Malekzadeh Kebria; Peiman Brouki Milan; Noshad Peyravian; Jafar Kiani; Soheil Khatibi; Masoud Mozafari
Journal:  Mol Biomed       Date:  2022-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.